Cumulative Use of Proton Pump Inhibitors and Risk of Dementia-Reference-Cited by-同舟云学术

Cumulative Use of Proton Pump Inhibitors and Risk of Dementia

Published:2023-10-31 Issue:18 Volume:101 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Northuis Carin A.¹,Bell Elizabeth J.¹,Lutsey Pamela L.¹^ORCID,George Kristen M.¹,Gottesman Rebecca F.¹,Mosley Tom H.¹,Whitsel Eric A.¹^ORCID,Lakshminarayan Kamakshi¹

Affiliation:

1. From the University of Minnesota (C.A.N., P.L.L., K.L.), Minneapolis; Optum (E.J.B.), Minneapolis, MN; University of California, Davis (K.M.G.); National Institute of Neurological Disorders and Stroke (R.F.G.), Washington, DC; University of Mississippi Medical Center (T.H.M.), Jackson; and University of North Carolina (E.A.W.), Chapel Hill.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000207747

Reference49 articles.

1. Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence;Maes ML;Ther Adv Drug Saf.,2017

2. The risks of long-term use of proton pump inhibitors: a critical review;Jaynes M;Ther Adv Drug Saf.,2019

3. Guidelines for the diagnosis and management of gastroesophageal reflux disease;Katz PO;Am J Gastroenterol.,2013

4. Deprescribing proton pump inhibitors: evidence-based clinical practice guideline;Farrell B;Can Fam Physician,2017

5. Proton pump inhibitor use in the U.S. ambulatory setting, 2002-2009;Rotman SR;PLoS One,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease;Annals of Neurology;2024-01-05

2. Cognitive Safety is Largely Ignored in Clinical Drug Trials: A Study of Registered Study Protocols;Drug Safety;2023-11-16